全球关节疼痛注射市场规模、份额、趋势和成长分析报告（2026-2034年）

预计关节疼痛注射市场将从 2025 年的 68 亿美元成长到 2034 年的 166.8 亿美元，2026 年至 2034 年的复合年增长率为 10.49%。

由于关节炎和关节疾病病例不断增加，全球关节疼痛注射市场持续稳定成长。人口老化和文明病相关疾病的增加也推高了对疼痛管理治疗的需求。皮质类固醇和透明质酸等注射剂无需大型手术即可缓解症状，因此推动了市场成长。

推动这一成长的主要动力是对微创治疗的认知度不断提高。医疗费用支出的增加和整形外科医疗服务可近性的改善进一步刺激了需求。注射技术的进步提高了安全性和有效性。门诊诊所的扩张也促进了市场成长。

未来，随着再生医学和生物製药注射技术的发展，市场可望扩张。然而，高昂的治疗费用和潜在的副作用可能会阻碍其广泛应用。总体而言，人们对行动能力和生活品质日益增长的关注可能会维持市场需求。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球关节疼痛注射市场：依注射类型划分

• 市场分析、洞察与预测
• 类固醇关节注射
• 玻尿酸注射
• 富血小板血浆（PRP）注射
• 胎盘组织基质（PTM）注射
• 其他类型的注射

第五章：全球关节疼痛注射市场：依关节类型划分

• 市场分析、洞察与预测
• 髋关节
• 膝关节和踝关节
• 肩部和肘部
• 脊椎的椎间关节
• 其他关节类型

第六章：全球关节疼痛注射市场：依通路划分

• 市场分析、洞察与预测
• 医院药房
• 零售药房
• 网路药房

第七章 全球关节疼痛注射市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Seikagaku Corporation
  • Flexion Therapeutics Inc
  • Zimmer Biomet Holdings Inc
  • Sanofi SA
  • Anika Therapeutics Inc
  • AbbVie Inc
  • Bioventus LLC
  • Eli Lilly And Company
  • Ferring Pharmaceuticals Inc
  • Pfizer Inc
  • Teva Pharmaceutical Industries Limited
  • Johnson & Johnson Services Inc
  • Merck & Co. Inc
  • GlaxoSmithKline Plc
  • Novartis AG

The Joint Pain Injections Market size is expected to reach USD 16.68 Billion in 2034 from USD 6.80 Billion (2025) growing at a CAGR of 10.49% during 2026-2034.

The global joint pain injections market has grown steadily due to rising cases of arthritis and joint disorders. Aging populations and lifestyle-related conditions have increased demand for pain management treatments. Injections such as corticosteroids and hyaluronic acid provide relief without major surgery, supporting market growth.

Major drivers include increasing awareness about minimally invasive treatments. Growing healthcare spending and improved access to orthopedic care further boost demand. Technological advancements in injection techniques have improved safety and effectiveness. Expanding outpatient care centers also support market expansion.

In the future, the market is expected to grow with the development of regenerative therapies and biologic injections. However, high treatment costs and possible side effects may limit adoption. Overall, increasing focus on mobility and quality of life will sustain demand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type of Injection

• Steroid Joint Injection
• Hyaluronic Acid Injections
• Platelet-Rich Plasma (PRP) Injections
• Placental Tissue Matrix (PTM) Injections
• Other Types of Injections

By Joint Type

• Hip Joint
• Knee And Ankle
• Shoulder And Elbow
• Facet Joints Of The Spine
• Other Joint Types

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Seikagaku Corporation, Flexion Therapeutics Inc, Zimmer Biomet Holdings Inc, Sanofi SA, Anika Therapeutics Inc, AbbVie Inc, Bioventus LLC, Eli Lilly and Company, Ferring Pharmaceuticals Inc, Pfizer Inc, Teva Pharmaceutical Industries Limited, Johnson Johnson Services Inc, Merck Co Inc, GlaxoSmithKline plc, Novartis AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL JOINT PAIN INJECTIONS MARKET: BY TYPE OF INJECTION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type Of Injection
• 4.2. Steroid Joint Injection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hyaluronic Acid Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Platelet-Rich Plasma (PRP) Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Placental Tissue Matrix (PTM) Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Types of Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL JOINT PAIN INJECTIONS MARKET: BY JOINT TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Joint Type
• 5.2. Hip Joint Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Knee And Ankle Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Shoulder And Elbow Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Facet Joints Of The Spine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Joint Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL JOINT PAIN INJECTIONS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL JOINT PAIN INJECTIONS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type Of Injection
  • 7.2.2 By Joint Type
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type Of Injection
  • 7.3.2 By Joint Type
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type Of Injection
  • 7.4.2 By Joint Type
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type Of Injection
  • 7.5.2 By Joint Type
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type Of Injection
  • 7.6.2 By Joint Type
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL JOINT PAIN INJECTIONS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Seikagaku Corporation
  • 9.2.2 Flexion Therapeutics Inc
  • 9.2.3 Zimmer Biomet Holdings Inc
  • 9.2.4 Sanofi S.A
  • 9.2.5 Anika Therapeutics Inc
  • 9.2.6 AbbVie Inc
  • 9.2.7 Bioventus LLC
  • 9.2.8 Eli Lilly And Company
  • 9.2.9 Ferring Pharmaceuticals Inc
  • 9.2.10 Pfizer Inc
  • 9.2.11 Teva Pharmaceutical Industries Limited
  • 9.2.12 Johnson & Johnson Services Inc
  • 9.2.13 Merck & Co. Inc
  • 9.2.14 GlaxoSmithKline Plc
  • 9.2.15 Novartis AG